Novonesis (Novozymes) A/S Asset Resilience Ratio

Latest as of March 2026: 0.01%

Novonesis (Novozymes) A/S asset resilience ratio. Novonesis (Novozymes) A/S (NSIS-B) has an Asset Resilience Ratio of 0.01% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Novonesis (Novozymes) A/S balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Dkr2.20 Million

≈ $344.19K USD Cash + Short-term Investments

Total Assets

Dkr16.52 Billion

≈ $2.59 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Novonesis (Novozymes) A/S (2002–2025)

Asset resilience ratio of Novonesis (Novozymes) A/S from 2002 to 2025. This chart shows how Novonesis (Novozymes) A/S's Asset Resilience Ratio has changed over time. See Novonesis (Novozymes) A/S (NSIS-B) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Liquid Assets Composition Over Time

This chart breaks down Novonesis (Novozymes) A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Novonesis (Novozymes) A/S total assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Dkr0.00	0%
Short-term Investments	Dkr2.20 Million	0.01%
Total Liquid Assets	Dkr2.20 Million	0.01%

Asset Resilience Insights

Limited Liquidity: Novonesis (Novozymes) A/S maintains only 0.01% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Novonesis (Novozymes) A/S Industry Peers by Asset Resilience Ratio

Compare Novonesis (Novozymes) A/S's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
International Flavors & Fragrances Inc NYSE:IFF	Specialty Chemicals	2.31%
Akzo Nobel NV AS:AKZA	Specialty Chemicals	2.16%
Incitec Pivot Ltd AU:IPL	Specialty Chemicals	0.03%
Luxi Chemical Group Co Ltd SHE:000830	Specialty Chemicals	0.43%
Tibet GaoZheng Explosive Co Ltd SHE:002827	Specialty Chemicals	1.20%
Zibo Qixiang Tengda Chemical Co Ltd SHE:002408	Specialty Chemicals	0.07%
Jilin OLED Material Tech Co Ltd SHG:688378	Specialty Chemicals	9.22%
Chongqing Zaisheng Tech Corp SHG:603601	Specialty Chemicals	13.69%

Novonesis (Novozymes) A/S Asset Resilience Ratio by Year (2002–2025)

Novonesis (Novozymes) A/S asset resilience ratio by year from 2002 to 2025. The table below shows the annual Asset Resilience Ratio data for Novonesis (Novozymes) A/S.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	0.12%	Dkr20.30 Million ≈ $3.18 Million	Dkr16.35 Billion ≈ $2.56 Billion	+0.10pp
2024-12-31	0.03%	Dkr4.00 Million ≈ $625.83K	Dkr15.20 Billion ≈ $2.38 Billion	-0.11pp
2023-12-31	0.14%	Dkr40.00 Million ≈ $6.26 Million	Dkr28.39 Billion ≈ $4.44 Billion	-0.14pp
2022-12-31	0.29%	Dkr80.00 Million ≈ $12.52 Million	Dkr27.98 Billion ≈ $4.38 Billion	-0.02pp
2021-12-31	0.30%	Dkr75.00 Million ≈ $11.73 Million	Dkr24.77 Billion ≈ $3.87 Billion	-0.28pp
2020-12-31	0.58%	Dkr119.00 Million ≈ $18.62 Million	Dkr20.51 Billion ≈ $3.21 Billion	+0.51pp
2019-12-31	0.07%	Dkr15.00 Million ≈ $2.35 Million	Dkr20.44 Billion ≈ $3.20 Billion	+0.00pp
2018-12-31	0.07%	Dkr14.00 Million ≈ $2.19 Million	Dkr19.70 Billion ≈ $3.08 Billion	-0.02pp
2017-12-31	0.09%	Dkr16.00 Million ≈ $2.50 Million	Dkr18.37 Billion ≈ $2.87 Billion	+0.07pp
2016-12-31	0.02%	Dkr4.00 Million ≈ $625.83K	Dkr18.66 Billion ≈ $2.92 Billion	-0.09pp
2015-12-31	0.11%	Dkr20.00 Million ≈ $3.13 Million	Dkr17.79 Billion ≈ $2.78 Billion	+0.02pp
2014-12-31	0.09%	Dkr17.00 Million ≈ $2.66 Million	Dkr18.43 Billion ≈ $2.88 Billion	-0.43pp
2013-12-31	0.53%	Dkr87.00 Million ≈ $13.61 Million	Dkr16.51 Billion ≈ $2.58 Billion	+0.23pp
2012-12-31	0.30%	Dkr45.00 Million ≈ $7.04 Million	Dkr15.11 Billion ≈ $2.36 Billion	-0.05pp
2011-12-31	0.35%	Dkr48.00 Million ≈ $7.51 Million	Dkr13.84 Billion ≈ $2.17 Billion	-1.07pp
2010-12-31	1.41%	Dkr178.00 Million ≈ $27.85 Million	Dkr12.59 Billion ≈ $1.97 Billion	-0.81pp
2006-12-31	2.22%	Dkr177.00 Million ≈ $27.69 Million	Dkr7.96 Billion ≈ $1.25 Billion	+0.16pp
2005-12-31	2.07%	Dkr151.00 Million ≈ $23.63 Million	Dkr7.31 Billion ≈ $1.14 Billion	+0.76pp
2004-12-31	1.30%	Dkr93.00 Million ≈ $14.55 Million	Dkr7.13 Billion ≈ $1.12 Billion	-0.20pp
2003-12-31	1.51%	Dkr115.00 Million ≈ $17.99 Million	Dkr7.63 Billion ≈ $1.19 Billion	-0.48pp
2002-12-31	1.99%	Dkr166.00 Million ≈ $25.97 Million	Dkr8.35 Billion ≈ $1.31 Billion	--

pp = percentage points

About Novonesis (Novozymes) A/S

CO:NSIS-B Denmark Specialty Chemicals

Market Cap

$30.27 Billion

Dkr193.46 Billion DKK

Market Cap Rank

#876 Global

#5 in Denmark

Share Price

Dkr469.00

Change (1 day)

+0.04%

52-Week Range

Dkr342.00 - Dkr481.50

All Time High

Dkr508.57